LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 0.2174 | 0.0209 | -0.0602 | 0.0358 |
MDA-MB-231 | Dovitinib | 0.04 | uM | LJP5 | 0.9192 | 0.0716 | 0.8923 | 0.0953 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 1.0094 | 0.0146 | 1.0130 | 0.0201 |
MDA-MB-231 | Erlotinib | 0.04 | uM | LJP5 | 0.9152 | 0.0420 | 0.8860 | 0.0555 |
MDA-MB-231 | Foretinib | 0.04 | uM | LJP5 | 0.9220 | 0.0156 | 0.8944 | 0.0209 |
MDA-MB-231 | R406 | 0.04 | uM | LJP6 | 0.9856 | 0.0015 | 0.9805 | 0.0018 |
MDA-MB-231 | Pictilisib | 0.04 | uM | LJP6 | 0.7950 | 0.0410 | 0.7235 | 0.0527 |
MDA-MB-231 | Gefitinib | 0.04 | uM | LJP6 | 1.0602 | 0.0537 | 1.0802 | 0.0715 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP5 | 0.5644 | 0.1062 | 0.4115 | 0.1396 |
MDA-MB-231 | Geldanamycin | 0.04 | uM | LJP6 | 0.5234 | 0.0819 | 0.3541 | 0.1128 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP5 | 1.0591 | 0.0212 | 1.0797 | 0.0280 |
MDA-MB-231 | GSK1059615 | 0.04 | uM | LJP6 | 1.0088 | 0.0697 | 1.0100 | 0.0945 |
MDA-MB-231 | GSK1904529A | 0.04 | uM | LJP6 | 0.8206 | 0.0403 | 0.7580 | 0.0520 |
MDA-MB-231 | Omipalisib | 0.04 | uM | LJP6 | 0.5509 | 0.0536 | 0.3906 | 0.0783 |
MDA-MB-231 | GSK 690693 | 0.04 | uM | LJP5 | 0.8781 | 0.0584 | 0.8362 | 0.0771 |
MDA-MB-231 | GW843682X | 0.04 | uM | LJP6 | 0.8915 | 0.0273 | 0.8534 | 0.0359 |
MDA-MB-231 | HG-5-113-01 | 0.04 | uM | LJP5 | 0.9782 | 0.0475 | 0.9717 | 0.0639 |
MDA-MB-231 | HG-5-88-01 | 0.04 | uM | LJP6 | 0.8048 | 0.0533 | 0.7370 | 0.0695 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 1.0080 | 0.0460 | 1.0098 | 0.0617 |
MDA-MB-231 | JNK-9L | 0.04 | uM | LJP6 | 0.8123 | 0.0319 | 0.7466 | 0.0406 |
MDA-MB-231 | JW-7-24-1 | 0.04 | uM | LJP6 | 0.8303 | 0.0539 | 0.7716 | 0.0707 |
MDA-MB-231 | Lapatinib | 0.04 | uM | LJP6 | 0.8794 | 0.0097 | 0.8368 | 0.0124 |
MDA-MB-231 | LDN-193189 | 0.04 | uM | LJP5 | 1.0042 | 0.0265 | 1.0052 | 0.0355 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 1.0732 | 0.0248 | 1.0985 | 0.0326 |
MDA-MB-231 | Linsitinib | 0.04 | uM | LJP5 | 0.8141 | 0.0348 | 0.7489 | 0.0448 |